DRUG INFORMATION INSIDER ACCESS OF 2025/2026
EXAM QUESTIONS WITH 100% SUCCESS RATE
ADRENALINE (EPINEPHRINE) - ACP2
AMIODARONE - ACP2
ASPIRIN - ACP2
ATROPINE - CCP
BENZTROPINE (BENZATROPINE) - CCP
BOX JELLYFISH ANTIVENOM - ACP2
CALCIUM GLUCONATE - CCP
CEFTRIAXONE - ACP2
CLOPIDOGREL - ACP2
DEXAMETHASONE - ACP2
DROPERIDOL - ACP2
ENOXAPARIN - ACP2
,FENTANYL - ACP2
GLUCAGON - ACP2
GLUCOSE GEL - ACP2
GLUCOSE 5% - CCP
GLUCOSE 10% - ACP2
GLYCERYL TRINITRATE - ACP2
HEPARIN - ACP2
HYDROCORTISONE - ACP2
HYDROXOCOBALAMIN - ACP2
IBUPROFEN - ACP2
IPRATROPIUM BROMIDE - ACP2
KETAMINE - CCP
LEVETIRACETAM - CCP
,LIDOCAINE 1% (LIGNOCAINE 1%) - CCP
LORATADINE - ACP2
MAGNESIUM SULPHATE - ACP2
METHOXYFLURANE - ACP2
MIDAZOLAM - ACP2
MORPHINE - ACP2
NALOXONE - ACP2
ONDANSETRON - ACP2
OXYGEN - ACP2
OXYTOCIN - ACP2
DRUG CLASS - Sympathomimetic.
MECHANISM OF ACTION - Increases heart rate, myocardial contraction force, and causes
bronchodilation and peripheral vasoconstriction.
, PRESENTATION - Ampoule 1mg/1mL (1:1,000) and Ampoule 1mg/10mL (1:10,000).
ONSET DURATION - 30 seconds (IV) and 60 seconds (IM).
HALF-LIFE - 2 Minutes.
ROUTES - ACP2 - NEB, IM, IV; CCP - IO, IV INF, IO INF.
INDICATIONS - Cardiac Arrest, Anaphylaxis or Severe Allergic Reaction, Severe Life-Threatening
Bronchospasm or Silent Chest, Shock Unresponsive to Adequate Fluid Resuscitation,
Bradycardia with Poor Perfusion, Croup (Moderate to severe).
CONTRAINDICATIONS - NIL.
PRECAUTIONS - Hypertension, Hypovolaemic Shock, Concurrent MAOI Therapy, Quetiapine
Toxicity.
SIDE EFFECTS - Anxiety, Hypertension, Palpitations/Tachyarrhythmias, Pupil dilation, Tremor.
ADULT DOSAGES - Cardiac Arrest - 1mg IV, repeated at 3 - 5 minutes, No Max Dose.
ADULT DOSAGES - Anaphylaxis or Severe Allergic Reaction - 500mcg IM, repeated at 5 minutes,
No Max Dose.
ADULT DOSAGES - NEB - 5mg for upper airway obstruction refractory to 3 x IM adrenaline
injections, Single Dose Only.